These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 1119535)
21. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849 [TBL] [Abstract][Full Text] [Related]
22. [Evolving aspects of uremic osteodystrophy in the dialized patient]. Zucchelli P; Fusaroli M; Fabbri L; Catizone L; Pavlica P; Viglietta G; Casanova S J Urol Nephrol (Paris); 1976; 82(4-5):325-8. PubMed ID: 940176 [No Abstract] [Full Text] [Related]
23. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289 [TBL] [Abstract][Full Text] [Related]
24. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis]. Bagon J; Brunfaut C J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994 [No Abstract] [Full Text] [Related]
25. Calcium and phosphorus metabolism in maintenance hemodialysis. Ritz E; Mehls O; Krempien B Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320 [No Abstract] [Full Text] [Related]
26. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. Quarles LD; Lobaugh B; Murphy G J Clin Endocrinol Metab; 1992 Jul; 75(1):145-50. PubMed ID: 1619003 [TBL] [Abstract][Full Text] [Related]
27. Plasma calcitonin in renal osteodystrophy. Chittal SM; Oreopoulos DG; DeVeber GA; Thomas P; Rabinovich S; Lloyd GJ; Kumar MA; Rapoport A Can Med Assoc J; 1971 Jun; 104(12):1098-100. PubMed ID: 4931771 [TBL] [Abstract][Full Text] [Related]
35. Renal osteodystrophy in course of periodic dialysis for chronic uremia. Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557 [No Abstract] [Full Text] [Related]
36. A comparison of bone scans in uremic patients treated with intermittent peritoneal dialysis or hemodialysis. Plotast H; Grzegorzewska AE; Junik R; Sowinski J; Gembicki M Perit Dial Int; 1996; 16 Suppl 1():S312-6. PubMed ID: 8728214 [TBL] [Abstract][Full Text] [Related]
37. Effect of verapamil on bone resorption and formation in uremic rats. Chagnac A; Gazit D; Zahavi I; Sela J; Levi J Miner Electrolyte Metab; 1989; 15(5):291-4. PubMed ID: 2811787 [TBL] [Abstract][Full Text] [Related]
38. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat. Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007 [TBL] [Abstract][Full Text] [Related]
39. [Some characteristics of phosphorus-calcium metabolism and the bone system pathology in chronic uremia]. Ermolenko VM; Nikiforova NV; Migunova NA; Bochman NL; Rassokhin BM Ter Arkh; 1973 May; 45(5):70-8. PubMed ID: 4768378 [No Abstract] [Full Text] [Related]
40. Changes in protein-bound calcium during haemodialysis in relation to bone disease. Gosling P; Naik RB; Price CP; Sammons HG; Robinson BH Nephron; 1979; 23(4):187-90. PubMed ID: 38410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]